Projects

Mgr. Jan Roška, PhD.

National

Current
  • Regulation of iron transport as a factor contributing to the chemoresistance of testicular tumours
    Program: VEGA
    Duration: 1. 1. 2024 – 31. 12. 2027
  • Role of DNA damage and repair in response of urogenital cancers to cisplatin-based chemotherapy
    Program: VEGA
    Duration: 1. 1. 2023 – 31. 12. 2026
  • Nanoceria - the complementary treatment to sensitize testicular tumors not responding to platinum agents
    Program: VEGA
    Duration: 1. 1. 2025 – 31. 12. 2025
Finished
  • Is hypoxia a master modulator of DNA repair capacity and mitochondrial dynamics in chemotherapy response in urogenital malignancies?
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2024
  • Is HIF-1a a master regulator of DNA repiar capacity and chemotherapy response in testicular germ cell tumors?
    Program: SRDA
    Duration: 1. 7. 2020 – 31. 12. 2023
  • Molecular biomarkers of relapse in seminoma clinical stage I patients
    Program: Other projects
    Duration: 1. 10. 2019 – 21. 12. 2022
  • Turning cisplatin-resistant testiular germ cell tumors into a curable disease
    Program: SRDA
    Duration: 1. 8. 2018 – 31. 12. 2021
  • Is DNA repair beyond good curability in testicular germ cell tumours?
    Program: VEGA
    Duration: 1. 1. 2017 – 31. 12. 2020
Employees